Clenergen Corporation was pleased to announce this morning that it has closed the previously announced share exchange agreement with Clenergen Corporation Limited, a United Kingdom Corporation (”Clenergen UK”). As previously agreed upon, the company issued 13,643,045 restricted shares of its common stock to the former shareholders of Clenergen UK.

Clenergen was also pleased to announce that it has appointed Dr. Arvind Pandalai, Mr. Robert Kohn, Mr. David Sonnenberg, Mr. Mike Starkie, Mr Dale Shepherd and Mr. Jack Dickey to its board of directors. Details regarding the closing of the share exchange agreement can be found in the company’s continuous disclosure documents as filed on www.sec.gov.

Let us hear your thoughts: Clenergen Corporation Message Board

Clenergen Corp. is a biofuels company that is approaching the sector from a different perspective – from an agronomy/biology and plantation standpoint. The company’s goal is to produce high-density, short-rotation biomass crops on a commercial scale which will then be used to power, steam and perhaps produce other products from advanced gasification and steam technologies.

The company is led by an eminent Board of Directors and Advisors. Here is a brief overview of the members:

Dr. Arvind Pandalai – Non-Executive Group Chairman

Dr. Pandalai has 32 years of experience in international trading, export and import management, joint ventures, project and financial management along with strategic planning. He has numerous prestigious management awards in his native India.

Robert Kohn – Non-Executive Vice-Chairman, North America

Mr. Kohn has been chairman/CEO, president/COO, and co-founder of three start-up public companies, with a combined market cap of over $1.5 billion.

Clenergen Corp. has developed a unique system of co-gasification and localized plantation management using proprietary and mixed biomass feedstocks to implement sustainable supplies of clean energy to regional, independent clients and national electric grids. The “distributed environmental power system” or DEPS combines significant proprietary advancements in plant science with proven, long-standing engineering technologies to achieve the goal of renewable and sustainable supplies of electricity.

Clenergen has an absolutely outstanding group of scientific advisors and non-executive directors to guide them on a path to future success. Here is a brief overview of the group:

Dr. N. Barathi – Biotechnology Science Advisor

Dr. N. Barathi has 25 years of experience in plant propagation by tissue culture and cultivation of plants. He has conducted research in bamboo for the past 10 years and identified an ideal bamboo clone for energy plantation and standardized agronomical management and agriculture